Form 4: Codexis Director Raymond De Vre Acquires Over 40,000 Shares in Equity Grant

Raymond De Vre, a Director at Codexis, Inc. (CDXS), has acquired 40,983 shares of common stock through a restricted stock unit grant, increasing his total beneficial ownership to 88,829 shares.

Summary

• Raymond De Vre, a Director of Codexis, Inc. (CDXS), acquired 40,983 shares of common stock on June 10, 2025.
• The acquisition was a grant of restricted stock units (RSUs) at a price of $0 per share.
• Following this transaction, Mr. De Vre's direct beneficial ownership of Codexis common stock increased to 88,829 shares.
• The restricted stock units are set to vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent upon Mr. De Vre's continued service to the Company.

Sentiment

Score: 6

Explanation: Slightly positive, as it indicates alignment of interests between a director and shareholders through equity compensation, which is a standard and expected practice.

Positives

• The acquisition of shares by a director, even through a grant, aligns the director's interests with those of the shareholders, potentially indicating confidence in the company's future performance.
• Equity compensation is a standard practice for attracting and retaining qualified board members.

Risks

• The vesting of the restricted stock units is subject to the director's continued service, meaning the shares are not immediately owned outright and could be forfeited if service ceases before vesting.

Future Outlook

The acquired restricted stock units are expected to vest on the earlier of June 10, 2026 (first anniversary of grant) or the date of the next annual stockholder meeting, provided the director remains in service.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity grant to a director, which is a common form of compensation across various industries, including biotechnology and specialty chemicals where Codexis operates.

Related Party Transactions

• The transaction itself is a related party transaction, as it involves the company granting equity to one of its directors as compensation.

Stakeholder Impact

• Shareholders: The grant of RSUs may result in minor dilution upon vesting, but it also aligns the director's financial interests with long-term shareholder value.
• Employees: No direct impact mentioned.

Next Steps

• Vesting of the 40,983 restricted stock units on the earlier of the first anniversary of the grant date (June 10, 2026) or the next annual stockholder meeting, subject to continued service.

Key Dates

Keywords

Codexis, CDXS, SEC Form 4, Insider Transaction, Director Stock Acquisition, Restricted Stock Units, Equity Grant, Beneficial Ownership, Corporate Governance